Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Lord

Showing results (121-130 of 223) with videos related to

Pageof 23
Sort By:
The Journal of Pathology. Clinical Research|April 17, 2018
Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancersSaira Khalique, Kalnisha Naidoo, Ayoma D Attygalle, et al.
Breast Cancer Research and Treatment|August 19, 2009
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancersRachael Natrajan, Britta Weigelt, Alan Mackay, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2010
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization studyMaryou B Lambros, Rachael Natrajan, Felipe C Geyer, et al.
Oncogene|June 29, 2022
Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress toleranceDalia Tarantino, Callum Walker, Daniel Weekes, et al.
British Journal of Cancer|February 16, 2026
Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cellsJenni Nikkilä, Rahul Kumar, James Campbell, et al.
British Journal of Cancer|May 24, 2017
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cellsJenni Nikkilä, Rahul Kumar, James Campbell, et al.
Molecular Oncology|October 22, 2023
Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7Joseph S Baxter, Rachel Brough, Dragomir B Krastev, et al.
Oncotarget|June 25, 2020
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastomaDavid King, Xiao Dun Li, Gilberto S Almeida, et al.
Gut|August 24, 2017
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancerIrene Yushing Chong, Lauren Aronson, Hanna Bryant, et al.
FEBS Letters|February 23, 2026
Genetic interactions, synthetic lethality and complexity in cancer vulnerability mapping-Insights and perspectives from the 2nd EuroDepMap symposiumLudovica Proietti, Pedro Beltrao, Alejandra Bruna, et al.
Pageof 23

Showing results (121-130 of 223) with videos related to

Sort By:
Pageof 23
The Journal of Pathology. Clinical Research|April 17, 2018
Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancersSaira Khalique, Kalnisha Naidoo, Ayoma D Attygalle, et al.
Breast Cancer Research and Treatment|August 19, 2009
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancersRachael Natrajan, Britta Weigelt, Alan Mackay, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2010
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization studyMaryou B Lambros, Rachael Natrajan, Felipe C Geyer, et al.
Oncogene|June 29, 2022
Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress toleranceDalia Tarantino, Callum Walker, Daniel Weekes, et al.
British Journal of Cancer|February 16, 2026
Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cellsJenni Nikkilä, Rahul Kumar, James Campbell, et al.
British Journal of Cancer|May 24, 2017
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cellsJenni Nikkilä, Rahul Kumar, James Campbell, et al.
Molecular Oncology|October 22, 2023
Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7Joseph S Baxter, Rachel Brough, Dragomir B Krastev, et al.
Oncotarget|June 25, 2020
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastomaDavid King, Xiao Dun Li, Gilberto S Almeida, et al.
Gut|August 24, 2017
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancerIrene Yushing Chong, Lauren Aronson, Hanna Bryant, et al.
FEBS Letters|February 23, 2026
Genetic interactions, synthetic lethality and complexity in cancer vulnerability mapping-Insights and perspectives from the 2nd EuroDepMap symposiumLudovica Proietti, Pedro Beltrao, Alejandra Bruna, et al.
Pageof 23